Displaying 1 - 12 of 16

Display:

12 24 48

Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts

View

Metabolism, Alcohol & Toxicity

Panel Q/A

Webcasts

View

Metabolism, Alcohol & Toxicity

Welcome and Introduction to the Event and Keynote Speakers

Webcasts

View

Metabolism, Alcohol & Toxicity

System-based solutions for NAFLD in the UK

Webcasts

View

Metabolism, Alcohol & Toxicity

Current landscape of Non-invasive technologies and the Role of LiverMultiScan Quantitative Multiparametric MRI for Patient Ris...

Webcasts

View

Metabolism, Alcohol & Toxicity

Upcoming NASH Therapeutics; The Need for Non-Invasive Technologies

Webcasts

View

Metabolism, Alcohol & Toxicity

Wrap-up

Webcasts

View

Metabolism, Alcohol & Toxicity

Introduction

Webcasts

View

Metabolism, Alcohol & Toxicity

Q&A

Webcasts

View

Metabolism, Alcohol & Toxicity

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts

View

Metabolism, Alcohol & Toxicity

Clinical cases presentation and discussion

Webcasts

View

Metabolism, Alcohol & Toxicity

FAST score for identification of active fibrotic NASH

Webcasts

View

Displaying 1 - 12 of 16

Display:

12 24 48